• Investment

Joseph Carroll

Investment Partner


  • Extensive experience in the development and commercialization of innovative technologies in drug development and biopharmaceuticals.
  • Held senior roles in technology transfer at a number of prestigious institutions, where he facilitated greater academic-industry partnerships and led venture creation.
  • PhD in Molecular Biology.
  • In his spare time, Joseph likes to be outside – often hiking a new forest trail or skiing in fresh snow. He’s usually just trying to keep up with his dog Marmaduke. Joseph also volunteers with various conservation groups – trying to help preserve this gem of a planet.


Joseph joined Longview Innovation in 2018, where he works to identify and transform early-stage innovations into impactful companies.

Over his more than 25-year career in the biopharma, tech transfer, and business development sectors, Joseph has worked with diverse groups of stakeholders to enable the translation of technologies to impact the lives of patients in need. Joseph has extensive experience in pre-clinical drug development at biopharma companies such as Wyeth, Millennium Pharmaceuticals, and Sirna Therapeutics. He also co-founded a successful RNAi-based venture, Skinetics Biosciences, Inc.

Joseph held various senior executive roles in the technology transfer sector at several prestigious institutions, such as the University of Colorado, Dublin City University’s Biomedical Diagnostics Institute, and OHSU’s Knight Cancer Institute. In his various roles in these institutions, Joseph worked to commercialize innovative technologies, facilitate greater academic-industry partnerships, and lead new venture creation.

Joseph earned a PhD in Cellular and Molecular Biology from the State University of New York (SUNY) at Stony Brook and a BS from Beloit College.


AbMeta Therapeutics,

Taktos Therapeutics